Cargando…
Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
INTRODUCTION: Although there is growing evidence supporting the effectiveness of Janus kinase (JAK) inhibitors in treating alopecia areata, the high rate of recurrence following drug discontinuation has led to prolonged treatment courses and raised concerns about long-term safety. In clinical practi...
Autores principales: | Huang, Jundong, Tan, Zixin, Tang, Yan, Shi, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619649/ https://www.ncbi.nlm.nih.gov/pubmed/37920596 http://dx.doi.org/10.3389/fmed.2023.1287139 |
Ejemplares similares
-
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022) -
A Comment on JAK Inhibitors for Treatment of Alopecia Areata
por: Trüeb, Ralph Michel, et al.
Publicado: (2018) -
Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
por: HUANG, Jundong, et al.
Publicado: (2023) -
Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
por: Blume-Peytavi, Ulrike, et al.
Publicado: (2015) -
A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
por: Dillon, Kerry-Ann L
Publicado: (2021)